Cluster analysis of clinical, angiographic, and laboratory parameters in patients with ST-segment elevation

Oğuzhan Birdal1, Emrah İpek2, Mehmet Saygı3

  • 1Department of Cardiology, Ataturk University, Erzurum, 25240, Turkey. droguzhanbirdal@gmail.com.

PubMed

Insights

Hierarchical agglomerative clustering (HAC) identified two distinct patient groups in ST-segment elevation myocardial infarction (STEMI). Cluster 2 demonstrated a significantly higher mortality risk, suggesting HAC

Area of Science:

  • Cardiology
  • Machine Learning in Healthcare
  • Biostatistics

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a severe manifestation of coronary artery disease.
  • Accurate risk stratification is crucial for guiding STEMI treatment and discharge planning.
  • Hierarchical agglomerative clustering (HAC) offers a novel machine learning approach for patient categorization.

Purpose of the Study:

  • To investigate the utility of HAC in stratifying STEMI patients into distinct phenotypic clusters.
  • To compare the clinical outcomes, specifically mortality, between the identified patient clusters.

Main Methods:

  • A cohort of 3205 STEMI patients diagnosed between 2015 and 2023 was analyzed.
  • Hierarchical agglomerative clustering (HAC) was applied to categorize patients into two distinct clusters.
  • Outcomes, including mortality, were compared between the clusters using statistical analyses (chi-square, log-rank, Cox regression).

Main Results:

  • STEMI patients were divided into Cluster 1 (2731 patients) and Cluster 2 (474 patients).
  • Cluster 2 exhibited significantly higher mortality rates (23%) compared to Cluster 1 (5.4%) (P < 0.01).
  • Survival analysis and Cox regression confirmed a substantially increased risk of death in Cluster 2 (HR = 3.51, P < 0.001), even after adjusting for age and sex.

Conclusions:

  • Hierarchical agglomerative clustering (HAC) effectively categorizes STEMI patients into groups with differing prognoses.
  • The HAC method shows potential as a predictive tool for one-month mortality in STEMI patients.
  • This machine learning approach may aid in refining risk assessment and treatment strategies for STEMI.
Abstract